RegeneRx Biopharmaceuticals, Inc.

OTCPK:RGRX Stock Report

Market Cap: US$2.1k

RegeneRx Biopharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

J. Finkelstein

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure22.7yrs
CEO ownership1.2%
Management average tenureno data
Board average tenure21.6yrs

Recent management updates

No updates

Recent updates

CEO Compensation Analysis

How has J. Finkelstein's remuneration changed compared to RegeneRx Biopharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2023n/an/a

-US$2m

Dec 31 2022US$165kUS$74k

-US$2m

Sep 30 2022n/an/a

-US$2m

Jun 30 2022n/an/a

-US$2m

Mar 31 2022n/an/a

-US$2m

Dec 31 2021US$204kUS$80k

-US$2m

Sep 30 2021n/an/a

-US$2m

Jun 30 2021n/an/a

-US$1m

Mar 31 2021n/an/a

-US$2m

Dec 31 2020US$179kUS$80k

-US$2m

Sep 30 2020n/an/a

-US$2m

Jun 30 2020n/an/a

-US$2m

Mar 31 2020n/an/a

-US$1m

Dec 31 2019US$188kUS$82k

-US$1m

Sep 30 2019n/an/a

-US$1m

Jun 30 2019n/an/a

-US$1m

Mar 31 2019n/an/a

-US$1m

Dec 31 2018US$145kUS$102k

-US$2m

Sep 30 2018n/an/a

-US$312k

Jun 30 2018n/an/a

-US$1m

Mar 31 2018n/an/a

-US$809k

Dec 31 2017US$184kUS$150k

US$286k

Compensation vs Market: Insufficient data to establish whether J.'s total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare J.'s compensation with company performance.


CEO

J. Finkelstein (72 yo)

22.7yrs

Tenure

US$165,262

Compensation

Mr. J. J. Finkelstein has been the Chief Executive Officer and President of Regenerx Biopharmaceuticals Inc. since March 19, 2002 and has been its Director since 2002. Mr. Finkelstein has been responsible...


Board Members

NamePositionTenureCompensationOwnership
Allan Goldstein
Founder42.8yrsUS$156.54k1.06%
$ 22.4
J. Finkelstein
President22.8yrsUS$165.26k1.17%
$ 24.8
Joseph McNay
Independent Director22.8yrsUS$40.64k4.32%
$ 91.3
Mauro Bove
Independent Director20.4yrsUS$33.64k0%
$ 0
Jo-David Fine
Scientific Advisory Board Memberno datano datano data
Deepak Srivastava
Scientific Advisory Board Memberno datano datano data
Gabriel Sosne
Scientific Advisory Board Memberno datano datano data
Ewald Hannappel
Scientific Advisory Board Memberno datano datano data
Barrett Katz
Scientific Advisory Board Memberno datano datano data
R. Elsey
Independent Director14.2yrsUS$40.64k0.069%
$ 1.5
Hynda Kleinman
Scientific Advisory Board Memberno datano datano data
Alessandro Noseda
Independent Director5.7yrsUS$33.64k0%
$ 0

21.6yrs

Average Tenure

72yo

Average Age

Experienced Board: RGRX's board of directors are seasoned and experienced ( 21.6 years average tenure).